NEW YORK – Digital pathology company OptraScan this week sued Bangalore, India-based Morphle Labs for patent infringement.
In a filing in US District Court for the Western District of Texas, San Jose, California-based OptraScan alleged that Morphle Labs has infringed on its patents covering "multiple claims directed to the automated scanning of slides, including those with pathology tissue sections."
The suit concerns OptraScan US Patent Numbers 10,338,365 and10,586,376, titled, respectively, "Slide Storage, Retrieval, Transfer, and Scanning System for a Slide Scanner" and "Automated Method of Predicting Efficacy of Immunotherapy Approaches."
According to OptraScan, Morphle was made aware as of Nov. 17, 2022, that its slide reader products infringed on OptraScan's intellectual property but has continued to sell them throughout the US.
OptraScan asked the court to award it damages compensating it for the infringement and covering its attorney fees and a permanent injunction prohibiting future infringement.
OptraScan offers a line of OS-Ultra brightfield scanners that were CE marked last year.